Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIM Honesty Biopharmaceutical
Dalian, Liaoning, China
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
AIM Honesty Biopharmaceutical is a leading Chinese vaccine manufacturer and a key subsidiary of AIM Vaccine Co., Ltd. The company specializes in the research, development, and production of human vaccines, with a primary focus on hepatitis B prevention. Its flagship product is a recombinant hepatitis B vaccine (Hansenula Polymorpha), which has established a significant market share in China. AIM Honesty operates large-scale manufacturing facilities that comply with international GMP standards to support both domestic supply and global expansion efforts.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant protein
- Industry
- Biotech
Beyond the preview
Go deeper on AIM Honesty Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AIM Honesty Biopharmaceutical.